| Dr Claire Hunter Schmidt, OD | |
|
Raf Lakenheath 48 Mdg, Unit 5210 Box 230, Apo, AE 09461-0230 | |
| (011) 441-638528124 | |
| Not Available |
| Full Name | Dr Claire Hunter Schmidt |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | Raf Lakenheath 48 Mdg, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821254236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1639 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Eye Associates Od, Pa | 0648174128 | 9 |
News Archive
A majority of American women always or frequently read the labels of their prescribed or over the counter medications to see if they might work differently in women, but few discuss this issue with their doctor or pharmacist, according to a new survey released by the Society for Women's Health Research, a Washington, D.C., based advocacy organization.
Researchers utilizing an advanced magnetic resonance imaging (MRI) technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE (glatiramer acetate injection) experienced significantly increased magnetization transfer ratio.
Researchers at Northwestern University have devised a method to induce embryonic stem cells to develop into bone marrow and blood cells. Injecting the stem cells into the bone marrow cavity of mice whose bone marrow cells had been depleted restored production of blood cells, including cells of the immune system, which normally are created in the bone marrow.
The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.
With rising concern over the cost of the new Medicare prescription drug benefit program – going into effect January, 2006 and estimated to cost $593 billion over the next decade – a new UCSF study reveals that a key cost-cutting strategy employed by HMOs for 15 years is simply not working.
› Verified 1 days ago
| Provider Name | University Eye Associates Od, Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831157866 PECOS PAC ID: 0648174128 Enrollment ID: O20040731000349 |
News Archive
A majority of American women always or frequently read the labels of their prescribed or over the counter medications to see if they might work differently in women, but few discuss this issue with their doctor or pharmacist, according to a new survey released by the Society for Women's Health Research, a Washington, D.C., based advocacy organization.
Researchers utilizing an advanced magnetic resonance imaging (MRI) technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE (glatiramer acetate injection) experienced significantly increased magnetization transfer ratio.
Researchers at Northwestern University have devised a method to induce embryonic stem cells to develop into bone marrow and blood cells. Injecting the stem cells into the bone marrow cavity of mice whose bone marrow cells had been depleted restored production of blood cells, including cells of the immune system, which normally are created in the bone marrow.
The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.
With rising concern over the cost of the new Medicare prescription drug benefit program – going into effect January, 2006 and estimated to cost $593 billion over the next decade – a new UCSF study reveals that a key cost-cutting strategy employed by HMOs for 15 years is simply not working.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Claire Hunter Schmidt, OD Raf Lakenheath 48 Mdg, Unit 5210 Box 230, Apo, AE 09461-0230 Ph: (011) 441-638528124 | Dr Claire Hunter Schmidt, OD Raf Lakenheath 48 Mdg, Unit 5210 Box 230, Apo, AE 09461-0230 Ph: (011) 441-638528124 |
News Archive
A majority of American women always or frequently read the labels of their prescribed or over the counter medications to see if they might work differently in women, but few discuss this issue with their doctor or pharmacist, according to a new survey released by the Society for Women's Health Research, a Washington, D.C., based advocacy organization.
Researchers utilizing an advanced magnetic resonance imaging (MRI) technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE (glatiramer acetate injection) experienced significantly increased magnetization transfer ratio.
Researchers at Northwestern University have devised a method to induce embryonic stem cells to develop into bone marrow and blood cells. Injecting the stem cells into the bone marrow cavity of mice whose bone marrow cells had been depleted restored production of blood cells, including cells of the immune system, which normally are created in the bone marrow.
The federal Centers for Disease Control and Prevention is awarding researchers at the Cook County Health & Hospitals System and Rush University Medical Center a $2 million grant to continue a successful program aimed at preventing healthcare-associated infections, antibiotic resistance, and other adverse events associated with healthcare.
With rising concern over the cost of the new Medicare prescription drug benefit program – going into effect January, 2006 and estimated to cost $593 billion over the next decade – a new UCSF study reveals that a key cost-cutting strategy employed by HMOs for 15 years is simply not working.
› Verified 1 days ago
Le Phan Andrus, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 52 Mdg, Unit 3690, Apo, AE 09126 Phone: 011-496-565618425 | |
Dr. Bob Sarivannara, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 48th Mdg, Unit 5115, Apo, AE 09461 Phone: 941-661-5903 | |
Angela Cho, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 39 Mdg/sgh, Unit 7095, Apo, AE 09824 Phone: 090-676-3344 | |
Amanda Kanwischer Gutierrez, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 52 Medical Group, Optometry Clinic, Spangdahelm Ab, Germany, Apo, AE 54529 Phone: 210-842-6957 | |
Dr. Clarence David Vesely, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Box 2078, Apo, AE 09180 Phone: 011-496-371868532 | |
Dr. James H Hsiau, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 31000, Apo, AE 09180 Phone: 314-566-5323 | |
Dr. Kristina Lynn Bartee, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center Unit 33100, Apo, AE 09180 Phone: 314-636-9754 |